2012 Society of Surgical Oncology Cancer Symposium

Matthew Stenger / April 15 2012 / 2012 Society of Surgical Oncology Cancer Symposium

Neoadjuvant Aromatase Inhibitor Therapy Converts Many Patients to Candidates for Breast-conserving Surgery

The American College of Surgeons Oncology Group (ACOSOG) Z1031 trial examined the effect of neoadjuvant aromatase inhibitor therapy on clinical response and breast-conservation rates in postmenopausal...

Breast Cancer

Matthew Stenger / May 15 2012 / 2012 Society of Surgical Oncology Cancer Symposium

Inhibition of SFRP2 Found to Inhibit Growth of Triple-negative Breast Tumors

Secreted frizzled related protein 2 (SFRP2), a protein that modulates the Wnt signaling pathway and is involved in embryonic development, has been thought to exert a tumor-suppressive effect via inhib...

Hepatobiliary Cancer

Matthew Stenger / May 15 2012 / 2012 Society of Surgical Oncology Cancer Symposium

Regional Infusion of Designer T Cells to Treat Intrahepatic Metastases

Designer T cells are modified from normal T cells to express specific immune receptors that allow them, via antibody-directed recognition or other mechanisms, to kill malignant cells bearing particula...

Oct

Today In Oncology

2012 Society of Surgical Oncology Cancer Symposium

Neoadjuvant Aromatase Inhibitor Therapy Converts Many Patients to Candidates for Breast-conserving Surgery

Inhibition of SFRP2 Found to Inhibit Growth of Triple-negative Breast Tumors

Regional Infusion of Designer T Cells to Treat Intrahepatic Metastases

FDA Approves Talazoparib for Deleterious Germline BRCA-Mutated HER2-Negative Locally Advanced or Metastatic Breast Cancer

Study Finds Deep Learning Can Distinguish Recalled-Benign Mammogram Images From Malignant and Negative Cases

FDA Accepts New Drug Application, Grants Priority Review to Selinexor for Pentarefractory Multiple Myeloma

Small Study of Neoadjuvant Combination Checkpoint Blockade in High-Risk Stage III Melanoma

Opioid Use Following Video-Assisted Thoracoscopic Surgery or Open Resection in Early-Stage Lung Cancer

KEYNOTE-407: First-Line Pembrolizumab Plus Chemotherapy in Metastatic Squamous NSCLC

Report Examines Shortages of Oncologists, Variation in Cancer Rates

IMpower133: Atezolizumab in Combination With Chemotherapy in Previously Untreated, Extensive-Stage Small Cell Lung Cancer

Cognitive Impairment in Patients With Breast Cancer Treated With Chemotherapy

Immune Checkpoint Blockade and Tumor-Specific Vaccine for Incurable HPV16-Related Cancer

Ursula A. Matulonis, MD, and Daniel J. Margul, MD, PhD, on Cervical Cancer and Minimally Invasive Surgery

Jay B. Shah, MD, on Reducing Opioid Use After Urologic Oncology Surgery

Frederick L. Locke, MD, on CAR T-Cell Therapy: Major Milestones

Angela M. Stover, PhD, on Patient-Reported Symptoms: Results From the STAR and PRO-TECT Trials

Lauren P. Wallner, PhD, MPH, on Thyroid Cancer: Reducing Overtreatment With Radioactive Iodine